Michael Dauner
DuPont
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Dauner.
Biotechnology Progress | 2008
Jochen Schaub; Carola Schiesling; Matthias Reuss; Michael Dauner
Metabolome analysis, the analysis of large sets of intracellular metabolites, has become an important systems analysis method in biotechnological and pharmaceutical research. In metabolic engineering, the integration of metabolome data with fluxome and proteome data into large‐scale mathematical models promises to foster rational strategies for strain and cell line improvement. However, the development of reproducible sampling procedures for quantitative analysis of intracellular metabolite concentrations represents a major challenge, accomplishing (i) fast transfer of sample, (ii) efficient quenching of metabolism, (iii) quantitative metabolite extraction, and (iv) optimum sample conditioning for subsequent quantitative analysis. In addressing these requirements, we propose an integrated sampling procedure. Simultaneous quenching and quantitative extraction of intracellular metabolites were realized by short‐time exposure of cells to temperatures ≤95 °C, where intracellular metabolites are released quantitatively. Based on these findings, we combined principles of heat transfer with knowledge on physiology, for example, turnover rates of energy metabolites, to develop an optimized sampling procedure based on a coiled single tube heat exchanger. As a result, this sampling procedure enables reliable and reproducible measurements through (i) the integration of three unit operations into a one unit operation, (ii) the avoidance of any alteration of the sample due to chemical reagents in quenching and extraction, and (iii) automation. A sampling frequency of 5 s−1 and an overall individual sample processing time faster than 30 s allow observing responses of intracellular metabolite concentrations to extracellular stimuli on a subsecond time scale. Recovery and reliability of the unit operations were analyzed. Impact of sample conditioning on subsequent IC‐MS analysis of metabolites was examined as well. The integrated sampling procedure was validated through consistent results from steady‐state metabolite analysis of Escherichia coli cultivated in a chemostat at D = 0.1 h−1.
Biotechnology Progress | 2008
Y. Sidorenko; A. Wahl; Michael Dauner; Yvonne Genzel; Udo Reichl
In mammalian cell cultures, ammonia that is released into the medium as a result of glutamine metabolism and lactate that is excreted due to incomplete glucose oxidation are both known to essentially inhibit the growth of cells. For some cell lines, for example, hybridoma cells, excreted ammonia also has an effect on product formation. Although glutamine has been generally considered as the major energy source for mammalian cells, it was recently found that various adherent cell lines (MDCK, CHO‐K1, and BHK21) can grow as well in glutamine‐free medium, provided glutamine is substituted with pyruvate. In such a medium the level of both ammonia and lactate released was significantly reduced. In this study, metabolic flux analysis (MFA) was applied to Madin Darby Canine Kidney (MDCK) cells cultivated in glutamine‐containing and glutamine‐free medium. The results of the MFA allowed further investigation of the influence of glutamine substitution with pyruvate on the metabolism of MDCK cells during different growth stages of adherent cells, e.g., early exponential and late contact‐inhibited phase. Pyruvate seemed to directly enter the TCA cycle, whereas most of the glucose consumed was excreted as lactate. Although the exact mechanisms are not clear so far, this resulted in a reduction of the glucose uptake necessary for cellular metabolism in glutamine‐free medium. Furthermore, consumption of ATP by futile cycles seemed to be significantly reduced when substituting glutamine with pyruvate. These findings imply that glutamine‐free medium favors a more efficient use of nutrients by cells. However, a number of metabolic fluxes were similar in the two cultivations considered, e.g., most of the amino acid uptake and degradation rates or fluxes through the branch of the TCA cycle converting α‐ketoglutarate to malate, which is responsible for the mitochondrial ATP synthesis. Besides, the specific rate of cell growth was approximately the same in both cultivations. Thus, the switch from glutamine‐containing to glutamine‐free medium with pyruvate provided a series of benefits without dramatic changes of cellular metabolism.
Biotechnology and Bioengineering | 2008
A. Wahl; Y. Sidorenko; Michael Dauner; Yvonne Genzel; Udo Reichl
Up to now cell‐culture based vaccine production processes only reach low productivities. The reasons are: (i) slow cell growth and (ii) low cell concentrations. To address these shortcomings, a quantitative analysis of the process conditions, especially the cell growth and the metabolic capabilities of the host cell line is required. For this purpose a MDCK cell based influenza vaccine production process was investigated. With a segregated growth model four distinct cell growth phases are distinguished in the batch process. In the first phase the cells attach to the surface of the microcarriers and show low metabolic activity. The second phase is characterized by exponential cell growth. In the third phase, preceded by a change in oxygen consumption, contact inhibition leads to a decrease in cell growth. Finally, the last phase before infection shows no further increase in cell numbers. To gain insight into the metabolic activity during these phases, a detailed metabolic model of MDCK cell was developed based on genome information and experimental analysis. The MDCK model was also used to calculate a theoretical flux distribution representing an optimized cell that only consumes a minimum of carbon sources. Comparing this minimum substrate consumption flux distribution to the fluxes estimated from experiments unveiled high overflow metabolism under the applied process conditions. Biotechnol. Biotechnol. Bioeng. 2008;101: 135–152.
Biotechnology and Bioengineering | 2001
Michael Dauner; James E. Bailey; Uwe Sauer
Biotechnology and Bioengineering | 2001
Michael Dauner; Uwe Sauer
Current Opinion in Biotechnology | 2010
Michael Dauner
Archive | 2013
Quinn Qun Zhu; Seung-Pyo Hong; Pamela L. Sharpe; Narendra S. Yadav; Xiaochun Fan; Michael Dauner
Archive | 2012
Michael Dauner; Robert DiCosimo; Ranjan Patnaik
Archive | 2013
Quinn Qun Zhu; Seung-Pyo Hong; Dongming Xie; Zhixiong Xue; Hyeryoung Yoon; Michael Dauner
Engineering Complex Phenotypes in Industrial Strains | 2012
Michael Dauner